Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Access Control
LeftNav
Alarms
LeftNav
Biometrics
LeftNav
Detection
LeftNav
Deutsche Zone (German Zone)
LeftNav
Education, Training and Professional Services
LeftNav
Government Programmes
LeftNav
Guarding, Equipment and Enforcement
LeftNav
Industrial Computing Security
LeftNav
IT Security
LeftNav
Physical Security
LeftNav
Surveillance
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
 
News

User authentication for highly regulated pharmaceuticals industry.

TriCipher : 24 October, 2007  (Company News)
TriCipher joins SAFE program to meet stringent pharmaceutical industry authentication and credential management requirements.
TriCipher has joined the SAFE (Signatures and Authentication for Everyone) BioPharma Association
Vendor Partner Program, pledging to promote the adoption of the SAFE standards through the company's user and transaction authentication solutions. SAFE-approved credentials will seamlessly operate on
TriCipher Armored Credential System (TACS), the company's strong authentication platform making use of a variety of multi-factor credentials.

The industry group gives TriCipher access to forward-thinking corporate users of digital information processing, such as Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson,
Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. By agreeing to credentialing standards, these companies reduce the cost and time for pharmaceutical companies to advance drug development and deploy new business processes.

SAFE provides the industry's legal foundation for digital signatures and user authentication across pharmaceutical companies. Its standards are legally enforceable because they ensure user authentication, digital document integrity and auditable non-repudiation of users' actions.

'The pharmaceutical industry sets the bar for other industries with highly regulated and valuable online activities,' said John De Santis, TriCipher's CEO. 'SAFE and TriCipher make it possible to get more
business value out of strong authentication credentials, increasing profits and better serving customers with faster product development and lower costs.'

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProSecurityZone.com
Netgains Logo